Meetings: Bacterial Contamination of Platelets; public workshop,

[Federal Register: August 26, 1999 (Volume 64, Number 165)]

[Notices]

[Page 46686]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr26au99-68]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Workshop on Bacterial Contamination of Platelets; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Bacterial Contamination of Platelets.'' The objectives of the public workshop are to obtain current information on bacterial contamination of platelets and to encourage future research and development efforts to minimize the risk of transfusion reactions. The public workshop will include an update on the epidemiology of platelet contamination, advances in detection methodology of contamination, and current strategies on bacterial inactivation and contamination avoidance. Results from a U.S. study (the BaCon Study) and similar European studies on microbial contamination will be presented.

Date and Time: The public workshop will be held on Friday, September 24, 1999, from 8:15 a.m. to 5 p.m.

Location: The public workshop will be held at the National Institutes of Health (NIH), NIH Clinical Center, Bldg. 10, Jack Masur Auditorium, 9000 Rockville Pike, Bethesda, MD.

Contact: Joseph Wilczek, Center for Biologics Evaluation and Research (CBER) (HFM-350), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827-6129, FAX 301-827-2843.

Registration and Requests for Oral Presentations: Mail or fax registration information (including name, title, firm name, address, telephone, and fax number) to Joseph Wilczek (address above) by Friday, September 10, 1999. Onsite registration will be done on a space- available basis on the day of the public workshop, beginning at 7:30 a.m. There is no registration fee for the public workshop. Space is limited, therefore, interested parties are encouraged to register early.

If you need special accommodations due to a disability, please contact Joseph Wilczek at least 7 days in advance.

A poster session will be set up for the public workshop. All participants are encouraged to present their study results in poster format. A limited number of abstracts may be selected for oral presentations. Send your abstracts and requests for oral presentations to Chiang Syin, Division of Transfusion Transmitted Diseases (HFM-320), CBER, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827-6465, FAX 301-594-6989, or e-mail ``syin@cber.fda.gov'' by Friday, September 10, 1999.

Transcripts: Transcripts of the meeting may be requested in writing from the Freedom of Information Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, approximately 15 working days after the meeting at a cost of 10 cents per page. The meeting transcript will also be available on CBER's website at ``http://www.fda.gov/cber/minutes/workshop-min.htm''.

Dated: August 17, 1999. William K. Hubbard, Senior Associate Commissioner for Policy, Planning and Legislation.

[FR Doc. 99-22098Filed8-25-99; 8:45 am]

BILLING CODE 4160-01-F